RQ 00433412

Drug Profile

RQ 00433412

Alternative Names: RQ 412

Latest Information Update: 22 Feb 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator RaQualia Pharma
  • Class Small molecules
  • Mechanism of Action Ghrelin receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Anorexia; Cachexia

Most Recent Events

  • 04 Dec 2015 Preclinical trials in Anorexia in Japan (PO) before December 2015
  • 04 Dec 2015 Preclinical trials in Cachexia in Japan (PO) before December 2015
  • 14 Sep 2015 Early research in Cachexia in Japan (PO) before September 2015
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top